$9.15
0.758.93%
Last update: Nov 4, 2:50 PM
Benitec Biopharma Inc
BNTCNASDAQ
The average analyst price target for Benitec Biopharma is $22.25, 143.2% above the current price. Of 12 analysts, 12 rate it Buy. Targets range from $13 to $32. The latest change came on Oct 23, 2026, when Raymond James initiated coverage of Benitec Biopharma with an Outperform rating and a $14 price target.
Price Target Range — 12 Quarters
Analyst Consensus — 12 Analysts
Rating Trend — Last 9 Months
